Species | Antimicrobials | SOS-induced biofilm targets | SOS | Effects on biofilm | References |
Gram negative | |||||
P. aeruginosa | Ofloxacin, norfloxacin and ceftazidime | LexA? | Increase | [10] | |
P. aeruginosa | Ofloxacin Ciprofloxacin | Persisters Toxin/antitoxin locus, tisAB/istR | LexA? LexA | Resistance Resistance | [93,94] [66,70] |
E. coli and P. aeruginosa | Aminoglycosides | LexA? | Increase | [6] | |
Vibrio cholerae | Bile acids | LexA? | Increase | [8] | |
P. aeruginosa | Hydroxyurea, nalidixic acid | LexA? | Increase | [11] | |
P. aeruginosa | Pf4 prophage | LexA? | Superinfection (SI) variants and DNA release | [43] | |
Multiple-species | Pyocyanin | Diversification | [87] | ||
E. coli | Phage engineered to overproduce LexA | LexA | Resistance | [40] | |
Pf4 phage superinfection variant | LexA | Maturation | [45] | ||
P. aeruginosa | Hydroxyurea, Ciprofloxacin | Cell motility and attachment | LexA LexA | Increase Increase | [12] [14] |
P. aeruginosa | Mismatch repair system (MRS) | Diversification, resistance evolution | [89,92] | ||
E. coli | Ofloxacin | Starvation | LexA | Tolerance | [72] |
E. coli | Cell attachment | LexA | Increase | [42] | |
E. coli | Bacteriocin | Colicin R | LexA | Decrease | [84] |
P. aeruginosa | Bacteriocin | Pyocin | LexA | Maturation | [83,85,86] |
E. coli and P. aeruginosa | Tetracycline and cephradine | LexA? | Increase Plasmid transfer | [57] | |
P. aeruginosa | Suppression of phage-related genes by CRISPR | LexA | Decrease | [52] | |
Gram positive | |||||
M. aviumwas | Hydrogen peroxide | LexA? | Increase | [9] | |
S. aureus | Fibronectin-binding proteins | LexA | Increase | [39] | |
S. aureus | RecA | LexA? | Increase | [38] | |
L. monocytogenes | YneA | LexA | Increase | [41] | |
L. monocytogenes | Superoxide and hydroxyl radicals | RecA | LexA? | Increase | [71] |